Answer
Relugolix in Ryeqo is a gonadotropin-releasing hormone (GnRH) receptor antagonist that suppresses ovarian production of estrogen and progesterone.
Sources for this answer
- Ryeqo 40mg/1mg/0.5mg film-coated tabletsGedeon Richter (UK) Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 6Document updated
Sources checked